cytarabine has been researched along with fialuridine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fox, JJ; Hirota, K; Lopez, C; Reichman, U; Watanabe, KA | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| King, DH | 1 |
| Balasubramaniam, NK; Gentry, GA; Veerisetty, V | 1 |
| Rollinson, EA | 1 |
| Bentele, B; Betz, JL; Mitchell, DH; Pizer, LI | 1 |
| Sougawa, M; Tanaka, Y; Yoshii, G | 1 |
| Chen, MS; Oshana, SC; Van Nostrand, M | 1 |
| Chou, TC; Fanucchi, MP; Fox, JJ; Watanabe, KA | 1 |
| Friedman-Kien, AE; Klein, RJ | 1 |
| Hsiung, GD; Mayo, DR | 1 |
| Gordon, M | 1 |
| Alauddin, M; Chan, PC; Chang, WT; Chang, WY; Chen, CL; Chen, FD; Lin, WJ; Liu, RS; Wang, HE; Wu, CY | 1 |
2 review(s) available for cytarabine and fialuridine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fluorinated pyrimidines: a new change for old drugs.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Arabinofuranosyluracil; Bone Marrow Transplantation; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Pyrimidines; Structure-Activity Relationship | 1991 |
12 other study(ies) available for cytarabine and fialuridine
| Article | Year |
|---|---|
Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides.
Topics: Antiviral Agents; Arabinonucleosides; Pyrimidine Nucleosides; Simplexvirus; Structure-Activity Relationship; Virus Replication | 1979 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Equine herpes virus 1 and pseudorabies virus resistance to 2'-fluoropyrimidine analogs and to bromovinyldeoxyuridine: implications for dTMP kinase activity.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cytarabine; Drug Resistance, Microbial; Herpesviridae; Herpesvirus 1, Suid; Horses; Nucleoside-Phosphate Kinase; Pseudorabies; Pyrimidine Nucleosides; Substrate Specificity | 1990 |
Comparative efficacy of three 2'-fluoropyrimidine nucleosides and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (BW B759U) against pseudorabies and equine rhinopneumonitis virus infection in vitro and in laboratory animals.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cricetinae; Cytarabine; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Equid; Herpesvirus 1, Suid; Male; Mice; Pseudorabies; Pyrimidine Nucleosides | 1987 |
A mammalian cell line designed to test the mutagenic activity of anti-herpes nucleosides.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cell Division; Cell Line; Cricetinae; Cricetulus; Cytarabine; DNA, Viral; Idoxuridine; Mutagenicity Tests; Nucleosides; Simplexvirus; Thymidine Kinase; Transfection; Trifluridine | 1987 |
[Radiosensitization effects of nucleoside analogs].
Topics: Acyclovir; Animals; Antineoplastic Agents; Arabinofuranosyluracil; Cytarabine; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Nucleosides; Radiation-Sensitizing Agents; Vidarabine; Whole-Body Irradiation | 1986 |
Quantitative determination of antiviral nucleoside analog in DNA.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cells, Cultured; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Cytarabine; DNA, Viral; Herpesviridae; Hydrolysis; Nucleosides | 1986 |
Kinetics and substrate specificity of human and canine cytidine deaminase.
Topics: Animals; Arabinofuranosyluracil; Cytarabine; Cytidine; Cytidine Deaminase; Deoxycytidine; Dogs; Humans; Kinetics; Liver; Nucleoside Deaminases; Substrate Specificity | 1986 |
Effect of eight antiviral drugs on the reactivation of herpes simplex virus in explant cultures of latently infected mouse trigeminal ganglia.
Topics: Acyclovir; Animals; Antibodies, Viral; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; Culture Media; Culture Techniques; Cytarabine; Foscarnet; Mice; Mice, Hairless; Neutralization Tests; Phosphonoacetic Acid; Simplexvirus; Thymidine; Trigeminal Nerve; Vidarabine Phosphate; Virus Activation | 1984 |
Treatment of primary acute genital herpes in guinea pigs by intraperitoneal administration of fluoropyrimidines.
Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cytarabine; Female; Foscarnet; Guinea Pigs; Herpes Genitalis; Injections, Intraperitoneal; Male; Phosphonoacetic Acid; Uridine; Virus Replication | 1984 |
Severe toxicity of fialuridine (FIAU)
Topics: Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Cytarabine; Drug Approval; Hepatitis B; Humans | 1996 |
Evaluation of F-18-labeled 5-iodocytidine (18F-FIAC) as a new potential positron emission tomography probe for herpes simplex virus type 1 thymidine kinase imaging.
Topics: Animals; Arabinofuranosyluracil; Cell Line, Tumor; Cytarabine; Female; Fluorine Radioisotopes; Herpesvirus 1, Human; Mice; Positron-Emission Tomography; Sarcoma; Thymidine Kinase; Transfection | 2011 |